M. Crump
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 7
- Neurology top 10%
- CNS Lymphoma Diagnosis and Treatment 2
- Hematology top 10%
- Hematopoietic Stem Cell Transplantation 2
-
- Colorectal Cancer Treatments and Studies 3
- Viral-associated cancers and disorders 2
-
- Breast Cancer Treatment Studies 3
-
- Ovarian cancer diagnosis and treatment 2
-
- Lung Cancer Treatments and Mutations 2
- Co-authors
- Frances A. ShepherdRichard TsangDavid HodgsonA. SunWoodrow WellsJayant Sastri GodaMary GospodarowiczMelania Pintilie
- Journals
- Journal of Clinical Oncology (5 papers)International Journal of Radiation Oncology*Biology*Physics (4 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- CanadaUnited StatesItaly
In The Last Decade
M. Crump
19 papers receiving 453 citations
Peers
Comparison fields: 5 of 52
- Pathology and Forensic Medicine 187
- Neurology 121
- Hematology 74
- Oncology 177
- Genetics 48
Countries citing papers authored by M. Crump
This map shows the geographic impact of M. Crump's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Crump with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Crump more than expected).
Fields of papers citing papers by M. Crump
This network shows the impact of papers produced by M. Crump. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Crump. The network helps show where M. Crump may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Crump, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 5 | |
| 2 | Efficacy and safety of bortezomib-rituximab (VCR) vs rituximab® in patients (PTS) with relapsed, R-naive/-sensitive follicular lymphoma (FL): outcome according to prior therapy | 2011 | 1 |
| 3 | 2011 | 15 | |
| 4 | 2011 | 1 | |
| 5 | 2010 | 149 | |
| 6 | 2007 | 0 | |
| 7 | 2004 | 56 | |
| 8 | 2004 | 1 | |
| 9 | 2004 | 22 | |
| 10 | 2004 | 2 | |
| 11 | 2004 | 2 | |
| 12 | 2004 | 1 | |
| 13 | 2001 | 29 | |
| 14 | 1999 | 2 | |
| 15 | 1997 | 13 | |
| 16 | Final results of the Canadian phase I dose escalation trial of gemcitabine and cisplatin for advanced non-small cell lung cancer. | 1996 | 8 |
| 17 | 1996 | 52 | |
| 18 | 1996 | 25 | |
| 19 | 1995 | 72 | |
| 20 | 1968 | 6 |
About M. Crump
M. Crump is a scholar working on Pathology and Forensic Medicine, Cancer Research, Reproductive Medicine, Oncology and Hematology, having authored 20 papers that have together received 462 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (7 papers), Colorectal Cancer Treatments and Studies (3 papers), Breast Cancer Treatment Studies (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Ovarian cancer diagnosis and treatment (2 papers), Viral-associated cancers and disorders (2 papers), Hematopoietic Stem Cell Transplantation (2 papers) and Lung Cancer Treatments and Mutations (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (187 citations), Neurology (121 citations), Hematology (74 citations), Oncology (177 citations) and Genetics (48 citations). M. Crump has collaborated with scholars based in Canada, United States and Italy. Frequent co-authors include Frances A. Shepherd, Richard Tsang, David Hodgson, A. Sun, Woodrow Wells, Jayant Sastri Goda, Mary Gospodarowicz, Melania Pintilie, Joseph Beyene and Lillian Sung. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Bone Marrow Transplantation, Cancer and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.